Community/Retail

The FDA has rejected Pfizer's supplemental new drug application to expand the use of tofacitinib citrate.

Neil Friedman, COO at Bodimetrics, describes the key functions and features of the Bodimetrics Performance Monitor.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses why DEA audits of pharmacies may be increasing.

Iris Gill recently celebrated her 4th birthday with a party completely inspired by her favorite pharmacy.

The FDA today approved Tris Pharma's extended-release amphetamine oral suspension (Dyanavel XR) for the treatment of ADHD in children aged 6 years and older.

Neil Friedman, COO at Bodimetrics, describes some of the key capabilities of the Bodimetrics Performance Monitor.

The current trend of hospitals purchasing physician practices to create efficiencies and ensure continuity of care seems to have resulted in increased costs of care.

A team of pharmacy students from the University of Arkansas for Medical Sciences College of Pharmacy won first prize.

Continuing its focus on America's growing long term care pharmacy sector as detailed by a new Avalere Health study, "Long-Term Care Pharmacy: The Evolving Marketplace and Emerging Policy Issues," the Senior Care Pharmacy Coalition today spotlighted the major differences between LTC pharmacies and more commonly known retail pharmacies.

Taxis may not only be a reliable mode of transportation for urbanites-they may also be frequent transmitters of the flu virus.

The student chapter of the National Community Pharmacists Association (NCPA) at the Bill Gatton College of Pharmacy at East Tennessee State University was recently awarded a high honor from the NCPA Foundation.

Rite Aid is celebrating the grand re-opening of a Baltimore store that sustained significant damage during the protests earlier this year.

This article discusses seven pieces of information pharmacists should know about praxbind, the newest antidote for dabigatran approved by the FDA

The FDA is encouraging the development of new abuse-deterrent technologies to combat opioid abuse.

DNA4Life has launched a new test for patients who want to know how their bodies will respond to some of the most commonly prescribed therapeutic medications.

A pharmacist accused of injecting his wife with a medication she did not need is no longer facing charges.

With the industry's greater focus for pharmacies on clinical performance and patient outcomes, Health Mart is hosting its third series of Town Hall events.

How should pharmacists react when the Drug Enforcement Administration arrives at their pharmacy, and how can pharmacists protect themselves during a DEA investigation?

New Jersey has enacted a law to stop the sale of OTC products containing dextromethorphan (DXM) to children under 18 without a prescription.

I hate seeing summer end, but a certain distraction takes me right to the middle of February without even missing it.

Price Chopper is selling plush primates and fundraising through a month-long pin-up campaign to raise money for St. Jude Children's Research Hospital.

Pharmacy Week is a time to celebrate one of the best professions in health care.

You don't have to be an expert in automation to know that technology is catching up with pharmacy.

Medline Industries is voluntarily recalling 1 lot of acetaminophen tablets.

A recent high-profile case of a celebrity allegedly indulging in "Herbal Viagra" and cocaine highlights an overlooked problem.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), discusses what pharmacists need to know about the memorandum of understanding regarding the interstate shipment of compounds.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses the nuances between a pharmacist's method of intervention versus the practices of other health providers.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, forecasts several different innovative solutions that are poised to drive better medication adherence over the next 2-3 years.

Complementary and alternative medicine use isn't uncommon among seniors, but it can predispose them to polypharmacy.

If all individuals with diabetic retinopathy were treated in a timely manner, the incidence of blindness from diabetes could be decreased by 90%.